Advice & guidance (A&G) has moved rapidly from a helpful clinical option to a core operational expectation across the NHS. Framed as a mechanism to reduce outpatient demand, improve access to specialist expertise, and support elective recovery, its expansion aligns strongly with national policy ambitions.
However, recent Health Service Journal reporting has made clear that the current trajectory of A&G is creating significant strain at the primary–secondary care interface and, in some cases, is contributing to backlogs rather than relieving them.
For NHS leaders, the lesson is not that A&G is the wrong policy, but that how it is implemented matters just as much as how much of it is done.
The reality for general practice
GPs are already operating under considerable pressure. Against this backdrop, A&G activity has grown sharply, often without corresponding reduction in other work. GPs increasingly report that A&G requests replace direct referrals but do not eliminate the need for ongoing patient management. Instead, they introduce additional clinical steps, follow‑up consultations, test ordering and increased clinical risk with unclear accountability.
The HSJ article highlights consultant concerns that A&G is adding friction into the system, particularly where it creates additional “holding work” for patients who are neither clearly accepted nor definitively managed. For GPs, this translates into expanded clinical responsibility for patients with unresolved symptoms, often without clear escalation thresholds or timelines.
Crucially, this is not perceived as collaborative working. Instead, it can feel like responsibility being pushed downstream at a time when general practice capacity is already stretched.
When advice becomes delay
One of the paradoxes identified in HSJ reporting is that A&G, intended to reduce waiting lists, can inadvertently extend patient journeys. Iterative advice cycles – requests for additional tests, repeated clarification, or non‑specific management suggestions – may keep patients in the system longer rather than moving them decisively to resolution.
From a GP perspective, this creates professional risk and inefficiency. The lack of standardisation across specialties and providers means advice quality and expectations vary widely. What constitutes “appropriate investigation” or “reasonable management in primary care” is often left to individual interpretation.
From a system perspective, this variability undermines flow. Patients remain active in primary care while simultaneously occupying advisory capacity in secondary care – increasing workload without clear ownership.
The missing ingredient: structured, symptom‑based pathways
The underlying problem is not A&G itself, but its frequent detachment from structured clinical pathways. Too often, A&G functions as a messaging layer between organisations rather than a shared model of care.
Without symptom‑based pathways:
- Advice is inconsistent and difficult to operationalise
- Accountability at the interface is unclear
- Escalation triggers are subjective rather than defined
- Learning and pathway improvement are limited
National guidance has repeatedly emphasised the importance of reducing unwarranted variation and clarifying responsibility at the primary–secondary care interface. However, these ambitions cannot be realised through unstructured advice alone.
How digital pathways can reset the interface
This is where platforms such as Bleepa offer a different proposition. Rather than positioning A&G as a standalone activity, Bleepa enables it to sit within clearly defined, symptom‑based pathways that are shared across primary and secondary care.
Bleepa creates a collaborative clinical workspace where GPs, consultants and diagnostics are connected around the patient. Advice is contextualised within pathways that define:
- Appropriate investigations
- Expected timelines
- Consistent, clear checkpoints and accountability
- Clear points of escalation and transfer of care
For GPs, this brings clarity and confidence. Advice is actionable rather than abstract, and responsibility is transparent. For secondary care clinicians, it ensures that guidance is aligned with agreed pathways rather than reinvented on a case‑by‑case basis.
Importantly, this approach addresses concerns raised by consultants in the article: that A&G is consuming time while, at times, failing to move patients forward. When embedded in structured pathways, A&G becomes a means of directing flow rather than suspending it.
Benefits for integrated care systems
At integrated care system level, structured A&G assisted by platforms like Bleepa supports several strategic priorities:
- Reduced variation: Symptom‑based pathways standardise decision‑making across populations.
- Improved demand management: Patients progress through defined routes, reducing iteration and duplication.
- Better use of specialist time: Consultants focus on pathway‑aligned advice rather than ad hoc triage.
- Improved data and governance: Pathway‑based activity can be monitored, refined and improved over time.
Most importantly, all these priorities improve productivity, moving the patient more rapidly through from referral to treatment. It helps rebuild trust at the interface – a recurring theme in both clinical feedback and national reviews.
A strategic choice for NHS leaders
HSJ’s reporting should be taken as a warning sign. Scaling A&G without adequate structure risks compounding the very problems it is meant to solve – increasing GP workload, slowing patient journeys, and frustrating clinicians on both sides of the interface.
The opportunity now is to mature A&G into a genuinely integrated model of care. By using digital platforms to embed A&G within symptom‑based pathways, NHS leaders can transform it from a transactional workaround into a cornerstone of safe, efficient, patient‑centred care.
The future of A&G will not be determined by volume targets alone, but by whether systems invest in the structure needed to make it work.